<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39442103</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1678-8060</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Memorias do Instituto Oswaldo Cruz</Title><ISOAbbreviation>Mem Inst Oswaldo Cruz</ISOAbbreviation></Journal><ArticleTitle>Detached epithelial cell plugs from the upper respiratory tract favour distal lung injury in Golden Syrian hamsters (Mesocricetus auratus) when experimentally infected with the A.2 Brazilian SARS-CoV-2 strain.</ArticleTitle><Pagination><StartPage>e240100</StartPage><MedlinePgn>e240100</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e240100</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/0074-02760240100</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0074-02762024000101131</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Golden Syrian hamster (Mesocricetus auratus), Ferrets (Mustela putorius furo), and macaques have been described as useful laboratory animals naturally susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To study the mechanism of lung injury, we describe the histopathological features of SARS-CoV-2 infection in Golden Syrian hamsters inoculated intranasally with the A.2 Brazilian strain.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Hamsters were intranasally inoculated with the A.2 variant and euthanised at 3-, 5-, 10- and 15-days post-inoculation. The physical examination and body weight were recorded daily. Neutralising antibodies and viral RNA load of the respiratory tract were assessed during necropsies.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The coronavirus disease 2019 (COVID-19) model presented body weight loss, high levels of respiratory viral RNA load, severe segmentary pneumonitis, and bronchial fistula besides lymphatic trapping and infiltration, like the human SARS-COV-2 pathogenesis. The presence of subepithelial lymphoeosinophilic infiltrate was highlighted in our results; it contributed to the detachment of SARS-CoV-2 nucleocapsid-positive epithelial cells resulting in the infectious cell plugs.</AbstractText><AbstractText Label="MAIN CONCLUSIONS" NlmCategory="CONCLUSIONS">The SARS-CoV-2 caused segmentary pneumonia and vascular damage. In our comprehension, the infectious cell plugs, as being aspirated from the upper respiratory tract into the terminal bronchial lumen, work as a "Trojan horse", thus contributing to the dissemination of the SARS-CoV-2 infection into specific regions of the deep lung parenchyma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pelajo-Machado</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Alexandre Dos Santos</ForeName><Initials>ADS</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Daniela Del Rosario Flores</ForeName><Initials>DDRF</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Milla Bezerra</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Bio-Manguinhos, Vice-Diretoria de Inovação, Departamento Experimental e Pré-Clínico, Laboratório de Ensaios Pré-Clínicos, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Luciana Jesus</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Virologia, Laboratório de Genética e Imunologia das Infecções Virais, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manso</LastName><ForeName>Pedro Paulo Abreu</ForeName><Initials>PPA</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>João Paulo Rodrigues</ForeName><Initials>JPR</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Emanuelle de Souza Ramalho Ferreira</ForeName><Initials>ESRF</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Central Analítica COVID-19, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Arthur Daniel Rocha</ForeName><Initials>ADR</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Jaqueline Mendes</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Marcelo Alves</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-3462-7277</Identifier><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Mem Inst Oswaldo Cruz</MedlineTA><NlmUniqueID>7502619</NlmUniqueID><ISSNLinking>0074-0276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008647" MajorTopicYN="Y">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="Y">Epithelial Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>16</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39442103</ArticleId><ArticleId IdType="pmc">PMC11493349</ArticleId><ArticleId IdType="doi">10.1590/0074-02760240100</ArticleId><ArticleId IdType="pii">S0074-02762024000101131</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Galambos C, Bush D, Abman SH. Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure. Eur Respir J. 2021;58(2):2004397–2004397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8051184</ArticleId><ArticleId IdType="pubmed">33863743</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, et al. Vascular disease and thrombosis in SARS-CoV-2-infected Rhesus macaques. Cell. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546181</ArticleId><ArticleId IdType="pubmed">33065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wong LYR, Li K, Verma AK, Ortiz ME, Wohlford-Lenane C. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589(7843):603–607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterrieder N, Bertzbach LD, Dietert K, Abdelgawad A, Vladimirova D, Kunec D. Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters. Viruses. 2020;12(7):779–779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412213</ArticleId><ArticleId IdType="pubmed">32698441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumbrun EE, Zak SE, Lee ED, Bowling PA, Ruiz SI, Zeng X. SARS-CoV-2 aerosol and intranasal exposure models in ferrets. Viruses. 2023;15(12):2341–2341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10747480</ArticleId><ArticleId IdType="pubmed">38140582</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S. Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters. J Virol. 2005;79(1):503–511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538722</ArticleId><ArticleId IdType="pubmed">15596843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834–838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7394720</ArticleId><ArticleId IdType="pubmed">32408338</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S, Goel G, Kumar A. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19. Int Rev Immunol. 2024;43(1):13–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">35757923</ArticleId></ArticleIdList></Reference><Reference><Citation>do Nascimento VA, Corado ALG, do Nascimento FO, da Costa AKA, Duarte DCG, Luz SLB. Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil. Mem Inst Oswaldo Cruz. 2020;115:e200310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523504</ArticleId><ArticleId IdType="pubmed">32997001</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoh OS, Nii-Trebi NI, Jakkari A, Olaniran TT, Senbadejo TY, Kafintu-Kwashie AA. Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in. Africa. iScience. 2022;25(3):103880–103880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817759</ArticleId><ArticleId IdType="pubmed">35156006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu L, Wei Q, Zhu H, Jiang H, Tu X. Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques. Virology. 2008;381(1):89–97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103406</ArticleId><ArticleId IdType="pubmed">18801550</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster VJ, Feldmann F, Williamson BN, van Doremalen N, Pérez-Pérez L, Schulz J. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020;585(7824):268–272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486227</ArticleId><ArticleId IdType="pubmed">32396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenough TC, Carville A, Coderre J, Somasundaran M, Sullivan JL, Luzuriaga K. Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am J Pathol. 2005;167(2):455–463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1603565</ArticleId><ArticleId IdType="pubmed">16049331</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques BBF, Guimarães TC, Fischer RG, Tinoco JMM, Pires FR, Lima JC, Jr, et al. Morphological alterations in tongue epithelial cells infected by SARS-CoV-2: a case-control study. Oral Dis. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447065</ArticleId><ArticleId IdType="pubmed">34342110</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak V, Waite J, Chalise SN. Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula. Lung India. 2021;38(Supplement):S69–S71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104334</ArticleId><ArticleId IdType="pubmed">33686984</ArticleId></ArticleIdList></Reference><Reference><Citation>Viecca M, Radovanovic D, Forleo GB, Santus P. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability A case control, proof of concept study. Pharmacol Res. 2020;158:104950–104950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244436</ArticleId><ArticleId IdType="pubmed">32450344</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–1561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9770920</ArticleId><ArticleId IdType="pubmed">32302453</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacono FJ. Control of ventilation in COPD and lung injury. Respir Physiol Neurobiol. 2013;189(2):371–376.</Citation><ArticleIdList><ArticleId IdType="pubmed">23856486</ArticleId></ArticleIdList></Reference><Reference><Citation>Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970;23(1):7–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC474401</ArticleId><ArticleId IdType="pubmed">4909103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryerson CJ, Olsen SR, Carlsten C, Donagh C, Bilawich AM, Field SK. Fibrosing bronchiolitis evolving from infectious or inhalational acute bronchiolitis A reversible lesion. Ann Am Thorac Soc. 2015;12(9):1323–1327.</Citation><ArticleIdList><ArticleId IdType="pubmed">26153612</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumenko V, Turk M, Jenne CN, Kim SJ. Neutrophils in viral infection. Cell Tissue Res. 2018;371(3):505–516.</Citation><ArticleIdList><ArticleId IdType="pubmed">29327081</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>